• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌(II-IVB期)术前放疗及手术后局部区域复发的危险因素。

Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).

作者信息

Shikama Naoto, Sasaki Shigeru, Nishikawa Atsushi, Koiwai Keiichirou, Yoshino Fuyumi, Hirase Yuichi, Kawakami Rei, Kadoya Masumi, Oguchi Masahiko

机构信息

Department of Radiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan.

出版信息

Radiology. 2003 Sep;228(3):789-94. doi: 10.1148/radiol.2283012044.

DOI:10.1148/radiol.2283012044
PMID:12954897
Abstract

PURPOSE

To discover possible risk factors for local-regional recurrence (LRR) following preoperative radiation therapy and curative surgery for head and neck squamous cell carcinoma (SCC) (stage II-IVB).

MATERIALS AND METHODS

Clinical records from 1987 to 1999 of 161 patients with head and neck SCC (oral cavity, 80 patients; larynx, 50; hypopharynx, 19; oropharynx, 12) who underwent preoperative radiation therapy and surgery were retrospectively reviewed. One hundred thirty-two (82%) of the patients had stage III or IV cancer. The median radiation dose was 38 Gy.

RESULTS

The 5-year overall survival rate and LRR rate were 58% and 35%, respectively. At multivariate analysis, oral cavity cancer (P =.020), clinical T stage (P =.016), clinical N stage (P =.017), and status of surgical margins (P =.008) emerged as variables that were significantly associated with LRR. The analysis of only those patients with lymph node involvement showed that oral cavity cancer (P =.008), advanced N-stage cancer (P =.045), and long interval between the start of preoperative radiation therapy and surgery (> or =7 weeks) (P =.019) emerged as variables that were significantly associated with LRR.

CONCLUSION

Oral cavity cancer, advanced T or N stage of disease, and unsatisfactory margins were risk factors for LRR. A long interval (> or =7 weeks) was a risk factor for LRR in patients with lymph node involvement.

摘要

目的

探寻头颈部鳞状细胞癌(II-IVB期)术前放疗及根治性手术后局部区域复发(LRR)的可能危险因素。

材料与方法

回顾性分析1987年至1999年161例接受术前放疗及手术的头颈部鳞状细胞癌患者(口腔癌80例、喉癌50例、下咽癌19例、口咽癌12例)的临床记录。132例(82%)患者为III期或IV期癌症。中位放疗剂量为38 Gy。

结果

5年总生存率和LRR率分别为58%和35%。多因素分析显示,口腔癌(P = 0.020)、临床T分期(P = 0.016)、临床N分期(P = 0.017)及手术切缘状态(P = 0.008)是与LRR显著相关的变量。仅对有淋巴结转移的患者进行分析显示,口腔癌(P = 0.008)、N期晚期癌症(P = 0.045)及术前放疗开始至手术的间隔时间长(≥7周)(P = 0.019)是与LRR显著相关的变量。

结论

口腔癌、疾病的T或N期晚期以及切缘不理想是LRR的危险因素。间隔时间长(≥7周)是有淋巴结转移患者发生LRR的危险因素。

相似文献

1
Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).头颈部癌(II-IVB期)术前放疗及手术后局部区域复发的危险因素。
Radiology. 2003 Sep;228(3):789-94. doi: 10.1148/radiol.2283012044.
2
The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.淋巴结转移对口腔、口咽、喉和下咽鳞状细胞癌治疗的影响:N0与N+的对比
Laryngoscope. 2005 Apr;115(4):629-39. doi: 10.1097/01.mlg.0000161338.54515.b1.
3
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
4
Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.头颈部鳞状细胞癌的调强放射治疗——爱荷华大学的经验
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21. doi: 10.1016/j.ijrobp.2005.02.025.
5
Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.术前超分割加速放疗联合根治性手术治疗晚期头颈癌:一项前瞻性II期研究。
Radiother Oncol. 2006 Feb;78(2):146-51. doi: 10.1016/j.radonc.2005.11.002. Epub 2005 Nov 22.
6
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.一项前瞻性随机试验的最终报告,该试验旨在评估头颈部癌患者术后放射治疗的剂量反应关系及病理风险组。
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1002-1011. doi: 10.1016/j.ijrobp.2017.02.218. Epub 2017 Jul 10.
7
Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.T3-4期口腔癌的动脉内放化疗:与口咽癌和下咽癌相比的治疗结果
World J Surg Oncol. 2008 Jan 14;6:2. doi: 10.1186/1477-7819-6-2.
8
Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.头颈部鳞状细胞癌调强放疗后远处转移。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):684-9. doi: 10.1016/j.ijrobp.2011.07.014. Epub 2011 Dec 12.
9
Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.70.6 Gy超分割加速放疗联合5-氟尿嘧啶/丝裂霉素C在局部晚期头颈癌治疗中优于单纯77.6 Gy超分割加速放疗:ARO 95-06随机III期试验的长期结果
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):916-24. doi: 10.1016/j.ijrobp.2014.12.034. Epub 2015 Feb 7.
10
Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.下咽和喉鳞状细胞癌术后放疗后的复发模式。
Acta Otolaryngol. 2015 Jan;135(1):96-102. doi: 10.3109/00016489.2014.949848. Epub 2014 Oct 29.